Dr. Reddy’s acquires 6 OTC brands in move into branded consumer care

PRINCETON, N.J. — Dr. Reddy’s is moving beyond prescription drugs and into consumer health care with a  new acquisition. The company announced Wednesday that it had purchased six OTC brands from Ducere Pharma, including Doan’s, Bufferin, Nupercainal Ointment, Cruex Nail Gel, Comtrex and Myoflex. 

 

“These legacy products enjoy strong brand equity built over several decades,” Dr. Reddy’s U.S. head and EVP Alok Sonig said. “We are extremely excited to be entering the branded consumer health arena through these brands and embarking upon the next avenue of growth for our OTC business in the U.S.”

 

Sonig said the company plans to build on the sales and marketing efforts for the newly acquired brands while focusing on expanding them into new and existing market channels. 

 

“We think Dr. Reddy’s is well-positioned to continue the successful growth of these brands,” Samuel F. Hines of Casla Capital Management said. “We feel confident that our brand-loyal consumers will be well-served by the deal.”